HEATHER LEE: Open Payments
NPI 1578938338 · KEY WEST, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,006 in 40 payments from 18 companies in 2025. Trend: 2023 $1,521 · 2024 $1,772 · 2025 $1,006
Food & beverage: $911Education: $95
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $294 |
| Astellas Pharma US Inc | 3 | $142 |
| Gilead Sciences, Inc. | 3 | $82 |
| E.R. Squibb & Sons, L.L.C. | 3 | $82 |
| AstraZeneca Pharmaceuticals LP | 2 | $59 |
| Syndax Pharmaceuticals, Inc. | 2 | $58 |
| SpringWorks Therapeutics, Inc. | 1 | $34 |
| Adaptive Biotechnologies Corporation | 1 | $32 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
Products named: KISQALI, Trodelvy, OPDIVO, PLUVICTO, LYNPARZA, LUTATHERA, Fabhalta, OGSIVEO.
Industry payments across FL — which companies pay providers there.
